Implementation strategies for the provision of fentanyl test strips in community pharmacies: Perspectives from pharmacy teams and harm reduction experts

This publication has 26 references indexed in Scilit:

• Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs
  JAMA Network Open, 2025
• The public health risks of counterfeit pills
  The Lancet Public Health, 2025
• Drug use practices and wound care experiences in the age of xylazine adulteration
  Drug and Alcohol Dependence, 2024
• Alabama community pharmacists’ knowledge and perceptions regarding fentanyl test strips: A cross-sectional survey
  Journal of the American Pharmacists Association, 2024
• “I go out of my way to give them an extra smile now:” A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials
  Research in Social and Administrative Pharmacy, 2024
• The availability of fentanyl test strips in Georgia community pharmacies
  Journal of the American Pharmacists Association, 2023
• Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services
  Drug and Alcohol Dependence, 2023
• Xylazine — Medical and Public Health Imperatives
  New England Journal of Medicine, 2023
• Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs
  International Journal of Drug Policy, 2021
• “You Never Know What You’re Getting”: Opioid Users’ Perceptions of Fentanyl in Southwest Pennsylvania
  Substance Use & Misuse, 2019